Junjun Li
No.69, Chuanshan Road
Hengyang, 421001, China
Hengyang, 421001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Triptonide enhances DNA damage by inhibiting TRIP13‑mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma.
Journal: International journal of oncology
Published: January 15, 2026
Efficacy and safety comparisons of PD-1 versus PD-L1 inhibitors in patients with solid cancer: a systematic review and meta-analysis.
Journal: Journal of the National Cancer Center
Published: August 21, 2025
Bronchial washing fluid supernatant serves as a novel liquid biopsy specimen for genome profiling in advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 17, 2025
Sulforaphane inhibits multiple myeloma cell-induced osteoclast differentiation and macrophage proliferation by elevating ferroportin1.
Journal: Cancer chemotherapy and pharmacology
Published: June 27, 2024
Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells.
Journal: Annals of hematology
Published: February 21, 2024
Diallyl disulfide synergizes with melphalan to increase apoptosis and DNA damage through elevation of reactive oxygen species in multiple myeloma cells.
Journal: Annals of hematology
Published: August 23, 2023
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial.
Journal: Annals of hematology
Published: August 10, 2023
CPEB2 enhances cell growth and angiogenesis by upregulating ARPC5 mRNA stability in multiple myeloma.
Journal: Journal of orthopaedic surgery and research
Published: February 27, 2023
LncRNA FEZF1-AS1 accelerates multiple myeloma progression by regulating IGF2BP1/BZW2 signaling.
Journal: Hematological oncology
Published: December 18, 2022
Diagnosis and treatment of multiple myeloma in Hunan Province.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: May 11, 2022
miR-140-3p attenuated the tumorigenesis of multiple myeloma via attenuating BZW2.
Journal: Hematology (Amsterdam, Netherlands)
Published: January 24, 2022
Cellular senescence and hematological malignancies: From pathogenesis to therapeutics.
Journal: Pharmacology & therapeutics
Published: December 12, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026